Gilead Sciences has criticized the Therapeutic Goods Administration’s (TGA) draft guidance on boxed warnings. The biotech warned the proposal could “drastically expand” use of the safety alerts and ...
Strengthens balance sheet and streamlines resources to advance robust pipeline of first-in-class and best-in-class drug candidates, and expand product portfolio through strategic transactions and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results